References

Chemo Secrets From a Breast Cancer Survivor

Breast Cancer Survivors

Get Instant Access

Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A., and Bennett, D.A. (2004). Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 61, 661-666.

Barbieri, M., Bonafe, M., Franceschi, C., and Paolisso, G. (2003). Insulin/IGF-I-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am. J. Physiol. Endocrinol Metab. 285, E1064-E1071.

Blasiak, J., Arabski, M., Krupa, R., Wozniak, K., Zadrozny, M., Kasznicki et al. (2004). DNA damage and repair in type 2 diabetes mellitus. Mutation Res. 554, 297-304.

Brownlee, M. (1995). Advanced protein glycosylation in diabetes and aging. Ann. Rev. Med. 46, 223-234.

Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.

Chaney, M.O., Baudry, J., Esh, C., Childress, J., Luehrs, D.C., Kokjohn, T.A. et al. (2003). A beta, aging, and Alzheimer's disease: A tale, models, and hypotheses. Neurological Res. 25, 581-589.

Chang, C.K. and Ulrich, C.M. (2003). Hyperinsulinaemia and hyperglycaemia: Possible risk factors of colorectal cancer among diabetic patients. Diabetologia 46, 595-607.

Coker, A.L., Sanderson, M., Zheng, W., and Fadden, M.K. (2004). Diabetes mellitus and prostate cancer risk among older men: population-based case-control study. Br. J. Cancer 90, 2171-2175.

Curb, J.D., Rodriguez, B.L., Abbott, R.D., Petrovich, H., Ross, G.W., Masaki, K.H. et al. (1999). Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 52, 971-975.

Flood, J.F., Mooradian, A.D., and Morley, J.E. (1990). Characteristics of learning and memory in streptozotocin-induced diabetic mice. Diabetes 39, 1391-1398.

Frey, M.I., Barett-Connor, E., Sledge, P.A., Schneider, D.L., and Weisman, M.H. (1996). The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J. Rheumatol. 23, 716-722.

Galasko, D. (2003). Insulin and Alzheimer's disease: an amyloid connection. Neurology 60, 1886-1887.

Galetic, I., Andielkovic, M., Meier, R., Brodbeck, D., Park, J., and Hemmings, B.A. (1999). Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase—Significance for diabetes and cancer. Pharmacol. & Therapeut. 82, 409-425.

Gavard, J.A., Lustman, P.J., and Clouse R.E. (1993). Prevalence of depression in adults with diabetes. Diabetes Care 16, 1167-1178.

Giannakou, M.E., Goss, M., Junger, M.A., Hafen, E., Leevers, S.J., and Partridge, L. (2004). Long-lived Drosophila with over expressed dFOXO in adult fat body. Science 305, 361.

Giovannucci, E. (2001). Insulin, insulin-like growth factors and colon cancer: A review of the evidence. J. Nutrition 131 (Suppl 11), 3109S-3120S.

Guastamacchia, E., Resta, F., Triggiani, V., Liso, A., Licchelli, B., Ghiyasaldin, S. et al. (2004). Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: Role of hormones, growth factors and specific receptors. Current Drug Targets—Immune Endocrine & Metabolic Disorders 4, 59-66.

Harris, M.I., Flegal, K.M., Cowie, C.C., Eberhardt, M.S., Goldstein, D.E., Little, R.R. et al. (1998). Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21, 518-524.

Hasanain, B. and Mooradian, A.D. (2002). Antioxidants and their influence in diabetes. Current Diabetes Reports 2, 448-456.

Hasnain, B.I. and Mooradian, A.D. (2004). Clinical implications of recent trials of antioxidant therapy: What should we be telling our patients? Cleveland Clin. J. Med. 71, 327-334.

Henderson, S.T. and Johnson, T.E. (2001). daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr. Biol. 11, 1975-1980.

Horani, M.H., Haas, M.J., and Mooradian, A.D. (2004). Rapid adaptive down regulation of oxidative burst induced by high dextrose in human umbilical vein endothelial cells. Diabetes Research and Clinical Practice 66, 7-12.

Hu, F.B., Meigs, J.B., Li, T.Y., Rifai, N., and Manson, J.E. (2004). Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 53, 693-700.

Idris, I., Gray, S., and Donnelly, R. (2001). Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44, 659-673.

Inzerillo, A.M. and Epstein, S. (2004). Osteoporosis and diabetes mellitus. Rev. Endocrine & Metabolic Disorders 5, 261-268.

Janson, J., Laedtke, T., Parisi, J.E., O'Brien, P., Petersen, R.C., and Butler, P.C. (2004). Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474-481.

Kalmijn, S., Feskens, E.J., Launer, L.J., Stijnen, T., and Kromhout, D. (1995). Glucose tolerance, hyperinsulinemia and cognitive function in a general population of elderly men. Diabetologia 38, 1096-1102.

Kawakami, T., Kawakami, Y., and Kitaura, J. (2002). Protein kinase C beta (PKC beta): Normal functions and diseases. J Biochem (Tokyo) 132, 677-682.

Kenyon, C., Chang, J., Gensch, E., Rudner, A., and Tabtiang, R. (1993). A C. elegans mutant that lives twice as long as wild type. Nature 366, 461-464.

Khaw, K.T., Wareham, N., Luben, R., Bingham, S., Oakes, S., Welch, A. et al. (2001). Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322, 15-18.

Khaw, K.T., Wareham, N., Bingham, S., Luben, R., Welch, A., and Day, N. (2004). Preliminary communication: Glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiology, Biomarkers & Prevention 13, 915-919.

Lustman, P.J., Griffith, L.S., Clouse, R.E., and Cryer, P.E. (1986). Psychiatric illness in diabetes mellitus: relation to symptoms and glucose control. J. Nerv. Ment. Dis. 174, 736-746.

Michels, K.B., Solomon, C.G., Hu, F.B., Rosner, B.A., Hankinson, S.E., Colditz, G.A. et al. (2003). Nurses' Health Study. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26, 1752-1758.

Mooradian, A.D. (1988a). Nutritional modulation of life span and gene expression. In J.E. Morley, Moderator, Nutrition in the elderly, pp. 891-892. Ann. Int. Med. 109, 890-904.

Mooradian, A.D. (1988b). Diabetic complications of the central nervous system. Endocrine Reviews 9, 346-356.

Mooradian, A.D. (1988c). Tissue specificity of premature aging in diabetes mellitus: The role of cellular replicative capacity. J. Am. Geriatr. Soc. 36, 831-839.

Mooradian, A.D. (1990). Biomarkers of aging: Do we know what to look for? J. Gerontol. Biol. Sci. 45, B183-B186.

Mooradian, A.D. (1994). Biology of Aging. In G. Felsenthal, S.J. Garrison, F.U. Steinberg, Eds., Rehabilitation of the Aging and Elderly Patient. Baltimore, MD: Williams and Wilkins, pp. 3-10.

Mooradian, A.D. (1995a). Theories of Aging. In J.E. Morley, Z. Glick, and L.Z. Rubenstein, Eds., Geriatric Nutrition: A Comprehensive Review. New York: Raven Press, pp. 5-13.

Mooradian, A.D. (1995b). The antioxidative potential of cerebral microvessels in experimental diabetes mellitus. Brain Res. 671, 164-169.

Mooradian, A.D. (1996). Glycosylation enhances malondialde-hyde binding to proteins. Free Radical Biol. Med. 21, 699-701.

Mooradian, A.D. (1997a). Central nervous system complications of diabetes mellitus. A perspective from the blood-brain barrier. Brain Res. Rev. 23, 210-218.

Mooradian, A.D. (1997b). Pathophysiology of central nervous system disorders in diabetes. Clin. Neurosci. 4, 322-326.

Mooradian, A.D. (2003). Cardiovascular disease in type 2 diabetes mellitus: Current management guidelines. Arch. Intern. Med. 163, 33-40.

Mooradian, A.D. and Chehade, J. (2000). Implications of the UK Prospective Diabetes Study: Questions answered and issues remaining. Drugs and Ageing 16, 159-164.

Mooradian, A.D., Chung, H.C., and Shah, G.N. (1997). GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol Aging 18, 469-474.

Mooradian, A.D. and Mariash, C.N. (1987). Effects of insulin and glucose on cultured rat hepatocyte gene expression. Diabetes 36, 938-943.

Mooradian, A.D., Perryman, K., Fitten, J., Kavonian, G., and Morley, J.E. (1988). Cortical function in elderly non-insulin dependent diabetic patients: Behavioral and electrophysiolo-gical studies. Arch. Int. Med. 148, 2369-2372.

Mooradian, A.D. and Thurman, J.E. (1999a). Drug therapy of postprandial hyperglycemia. Drugs 57, 19-29.

Mooradian, A.D. and Thurman, J. (1999b). Glucotoxicity: Potential mechanisms. Clinics in Geriatric Medicine 15, 255-263.

Mooradian, A.D. and Uko-eninn, A. (1995). Age-related changes in the antioxidative potential of cerebral microvessels. Brain Res. 671, 159-163.

Newton, A.C. (1995). Protein kinase C: Structure, function, and regulation. J. Biol. Chem. 270, 28495-28498.

Pardee, K., Reinking, J., and Krause, H. (2004). Nuclear hormone receptors, metabolism, and aging. Science 306, 1446-1447.

Rasgon, N. and Jarvik, L. (2004). Insulin resistance, affective disorders, and Alzheimer's disease: Review and hypothesis. J Gerontol. Series A-Biol. Sci. & Med. Sci. 59, 178-183.

Rohlfing, C.L., Wiedmeyer, H.M., Little, R.R., England, J.D., Tennill, A., and Goldstein, D.E. (2002). Defining the relationship between plasma glucose and HbA(1c): Analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 25, 275-278.

Ryan, C.M. (1988). Neurobehavioral complication of type 1 diabetes. Examination of possible risk factors. Diabetes Care 11, 86-93.

Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Takeuchi, M. et al. (2001). Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease. Brain Research 888, 256-262.

Schwartz, A.V. (2003). Diabetes mellitus: does it affect bone? Calc. Tissue Int. 73, 515-519.

Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F.L., Powe, N.R. et al. (2004). Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann. Intern. Med. 141, 421-431.

Shah, G.N. and Mooradian, A.D. (1997). Age-related changes in the blood brain barrier. Exp. Gerontol. 32, 501-519.

Sinagra, D., Amato, C., Scarpilta, A.M., Brigamdi, M., Amato, M., Saura, G. et al. (2002). Metabolic syndrome and breast cancer risk. Eur. Rev. Med. & Pharmacol. Sci. 6, 55-59.

Songer, T. (1995). Disability in diabetes. In M. Harris, C. Cowie, and M. Stern, Eds., Diabetes in America, 2e. Bethesda, MD: National Institute of Health; pp. 259-282.

Spranger, J., Kroke, A., Mohlig, M., Hoffmann, K., Bergmann, M.M., Ristow, M. et al. (2003). Inflammatory cytokines and the risk to develop type 2 diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52(3), 812-817.

Strachan, M.W., Deary, I.J., Ewing, F.M., and Frier, B.M. (1997). Is type 2 diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20, 438-445.

Stratton, I.M., Adler, A.I., Neil, H.A., Matthews, D.R., Manley, S.E., Cull, C.A. et al. (2000). Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321, 405-412.

UK Prospective Diabetes Study Group. (1998a). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853.

UK Prospective Diabetes Study. (1998b). Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865.

Watanabe, S., Takeuchi, Y., Fukumoto, S., Fujita, H., Nakano, T., and Fujita, T. (2003). Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients. J. Bone & Min. Metab. 21, 166-171.

Wehmeier, K.R. and Mooradian, A.D. (1994). Autooxidative and antioxidative potential of simple carbohydrate. Free Radical in Biol. Med. 17, 83-86.

Wu, L.L., Chiou, C.C., Chang, P.Y., and Wu, J.T. (2004). Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clinica Chimica Acta 339, 1-9.

Yang, Y.X., Hennessy, S., and Lewis, J.D. (2004). Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 127, 1044-1050.

Zendehdel, K., Nyren, O., Ostenson, C.G., Adami, H.O., Ekbom, A., and Ye, W. (2003). Cancer incidence in patients with type 1 diabetes mellitus: A population-based cohort study in Sweden. J. Nat. Cancer Inst. 95, 1797-1800.

Zhu, K., Lee, I.M., Sesso, H.D., Buring, J.E., Levine, R.S., and Gaziano, J.M. (2004). History of diabetes mellitus and risk of prostate cancer in physicians. Am. J. Epidemiol. 159, 978-982.

This page intentionally left blank

Was this article helpful?

0 0
Your Heart and Nutrition

Your Heart and Nutrition

Prevention is better than a cure. Learn how to cherish your heart by taking the necessary means to keep it pumping healthily and steadily through your life.

Get My Free Ebook


Post a comment